Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A
- 31 August 1999
- journal article
- Published by Elsevier in Tubercle and Lung Disease
- Vol. 79 (4), 251-259
- https://doi.org/10.1054/tuld.1998.0196
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- DNA VACCINESAnnual Review of Immunology, 1997
- Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNAGene Therapy, 1997
- An OspA-Based DNA Vaccine Protects Mice against Infection with Borrelia burgdorferiThe Journal of Infectious Diseases, 1997
- Expression and Immune Response to Hepatitis C Virus Core Dna-Based Vaccine ConstructsHepatology, 1996
- In vivo protective anti‐HIV immune responses in non‐human primates through DNA immunizationJournal of Medical Primatology, 1996
- DNA-Mediated Immunization in Mice Induces a Potent MHC Class I-Restricted Cytotoxic T Lymphocyte Response to the Hepatitis B Envelope ProteinHuman Gene Therapy, 1995
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Disseminated tuberculosis in interferon gamma gene-disrupted mice.The Journal of Experimental Medicine, 1993
- DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibodyHuman Molecular Genetics, 1993
- Adoptive protection of the Mycobacterium tuberculosis-infected lungCellular Immunology, 1984